Fennec Pharmaceuticals Inc

NEW
TSX:FRX (USA)  
C$ 14.9 (0%) Jul 22
At Loss
P/B:
9.96
Market Cap:
C$ 517.58M ($ 367.40M)
Enterprise V:
C$ 466.04M ($ 330.81M)
Volume:
101.00
Avg Vol (2M):
1.26K
Trade In:
Volume:
101.00
At Loss
Avg Vol (2M):
1.26K

Fennec Pharmaceuticals Inc (TSX:FRX) Dividend

Fennec Pharmaceuticals Inc (TSX:FRX) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -9%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: TSX:FRX Dividend

Does Fennec Pharmaceuticals Inc (TSX:FRX) pay a dividend?

Fennec Pharmaceuticals Inc (TSX:FRX) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Fennec Pharmaceuticals Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Fennec Pharmaceuticals Inc has returned capital to shareholders via buybacks at a rate of -9% over the past 3 years.

What are dividend-paying alternatives to Fennec Pharmaceuticals Inc?

For dividend-paying alternatives in Fennec Pharmaceuticals Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.